Memorial Sloan Kettering Cancer Center Royalty Pharma PLC Transaction History

Memorial Sloan Kettering Cancer Center

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $42.3 Million - $49.9 Million	-1,128,255 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $58.2 Million - $65.9 Million	-1,552,389 Reduced 57.91%	1,128,255 $44 Million
Q1 2021 May 17, 2021	SELL	$42.34 - $52.82 $37.5 Million - $46.8 Million	-885,243 Reduced 24.83%	2,680,644 $117 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $129 Million - $178 Million	3,565,887 New	3,565,887 $178 Million

397

291M

305K

138K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Memorial Sloan Kettering Cancer Center, based on Form 13F filings with the SEC.

Stay updated on Memorial Sloan Kettering Cancer Center with notifications on news.